Pfizer in South Africa was established in 1953. Since then the company has been shaped by developments within the global Pfizer group, including the acquisition of Warner Lambert, Pharmacia and most recently, Wyeth.
Brian Daniel, CEO & Country Manager for Pfizer South Africa’s Biopharmaceutical Division, notes that the recent acquisition of Wyeth has proved particularly positive for the company, having broadened the spectrum of diseases that Pfizer is able to address. ‘Our offering now spans medication for pain, women’s health, cardio-vascular health, neuroscience and vaccines’, he enthuses.
The addition of a vaccine offering is of particular importance because it is in line with government’s aims to address infant mortality.
Several of Pfizer’s medicine are world leaders in their therapeutic class.
Four of the company’s top ten products are world-leading pharmaceuticals discovered by scientists at the Pfizer discovery and development campus. These include medicines for treating high blood pressure and angina, the worlds best selling oral anti-fungal agent, a treatment for benign prostatic hypertrophy, and the first oral treatment for erectile dysfunction.
Research has concentrated recently on:
Diseases of the central nervous system
Metabolic diseases
Cancer
Cardiovascular diseases
Inflammatory diseases (rheumatoid arthritis and osteo-arthritis)
Viral diseases (HIV/AIDS)
Allergies and respiratory diseases
Sexual health
Research is also undertaken to improve the health of both farm livestock and family pets.
Pfizer prescription-only medicines include anti-infectives treatments for cardiovascular diseases, depression and erectile dysfunction anti inflammatories, anti-epileptics and many others.
Contact:
Address:85 Bute Rd, Sandown, Sandton, 2196, South Africa
Tel: 0860 734 937
The country manager and Global Established Products Business Lead at Pfizer South Africa reveals how the private sector is committed to expanding healthcare for South Africans, why her ambition is…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
The head of operations of Hetero South Africa talks about the need for a more efficient regulatory system with a fast track process for essential molecules, and how Hetero is…
The CEO of Ascendis Health talks about their business model, being a long-term investment company that brings together healthy businesses in the healthcare industry, and how the diversification of their product…
Merck’s managing director for South Africa and general manager for Southeast Africa reveals why the company takes a long-term perspective when investing in African countries, helping to shape healthcare systems,…
The general manager of Novagen Pharma reveals how they are the second largest supplier of ARVs within the private South African market, how there is much room for the generics…
The country manager and Global Established Products Business Lead at Pfizer South Africa reveals how the private sector is committed to expanding healthcare for South Africans, why her ambition is…
The country manager of Dr. Reddy´s South Africa explains that while the perception of the quality of generics has improved in South Africa, there is still a long way to…
The CEO of NAPM reveals how the main challenge facing his members is the length of time needed to register a generic product, taking up to four years and acting…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal (MDG) that same year.…
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and anti-infectives produced locally. To what extent…
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
See our Cookie Privacy Policy Here
